Laboratory tests for coagulation system monitoring in a patient with β-thalassemia

International Journal of Hematology

Volumn 99, Issue 5, 2014, Pages 588-596

  Seregina, Elena A ^c   Nikulina, Olga F ^a   Tsvetaeva, Nina V ^a   Rodionova, Maya N ^a   Gribkova, Irina V ^a   Orel, Elena B ^a   Zapariy, Anastasiya P ^d   Erasov, Anatoliy V ^d   Balandina, Anna N ^b,c   Ananyeva, Natalya M ^e   Ataullakhanov, Fazoil I ^a,b,c,d,f  

^a NATIONAL RESEARCH CENTER FOR HEMATOLOGY   (Russian Federation)

^b CENTER FOR THEORETICAL PROBLEMS OF PHYSICOCHEMICAL PHARMACOLOGY   (Russian Federation)

^c Federal Research Center of Pediatric Hematology   (Russian Federation)

^d HemaCore LLC   (Russian Federation)

^e CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^f MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Endogenous thrombin potential; Hemolytic anemia; Hypercoagulability; Hypercoagulation; Thalassemia; Thrombodynamics; Thalassemia

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BEMIPARIN; BILIRUBIN; BILIRUBIN GLUCURONIDE; CREATININE; D DIMER; ENOXAPARIN; FIBRINOGEN; HEMOGLOBIN; HEPARIN; HYDROXYUREA; LACTATE DEHYDROGENASE; LOW MOLECULAR WEIGHT HEPARIN; POTASSIUM; PROTHROMBIN; SODIUM;

ABDOMINAL PAIN; ADULT; ANTICOAGULANT THERAPY; ARTICLE; BETA THALASSEMIA; BLOOD CLOT; BLOOD CLOTTING; BLOOD SMEAR; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DOPPLER ECHOCARDIOGRAPHY; DRUG MEGADOSE; ERYTHROCYTE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HEPARINIZATION; HEREDITARY HEMOLYTIC ANEMIA; HUMAN; HYPERCOAGULABILITY; LABORATORY TEST; LEUKOCYTE COUNT; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PORTAL VEIN THROMBOSIS; POTASSIUM BLOOD LEVEL; RETICULOCYTE COUNT; SODIUM BLOOD LEVEL; SPLENECTOMY; SPLENOMEGALY; THROMBIN TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY; BETA-THALASSEMIA; BLOOD; BLOOD CLOTTING TEST; PROCEDURES; TREATMENT OUTCOME;

BETA-THALASSEMIA; BLOOD COAGULATION; BLOOD COAGULATION TESTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; SPLENECTOMY; TREATMENT OUTCOME;

EID: 84901603557     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-014-1559-1     Document Type: Article

References (26)

1. Schwartz RS. Autoimmune and intravascular haemolytic anemias. In: Goldman L, Schafer AI, editors. Cecil medicine. 24th ed. Philadelphia: Saunders Elsevier; 2011.
2. Cao A, Galanello R. Beta-thalassemia. Genet Med. 2010;2:61-76.
3. Ataga KI, Cappellini MD, Rachmilewitz EA. b-thalassemia and sickle cell anaemia as paradigms of hypercoagulability. Br J Haematol. 2007;139:3-13. (Pubitemid 47389919)
4. Stein PD, Beemath A, Meyers FA, Skaf E, Olson RE. Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med. 2006;119(897):e7-11.
5. Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood. 2002;99:36-43.
6. Hendrick AM. Auto-immune haemolytic anaemia: a high-risk disorder for thromboembolism. Hematology. 2003;8:53-6. (Pubitemid 36322354)
7. Taher A, Ismaeel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz EA, et al. Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost. 2006;96:488-91. (Pubitemid 44560684)
8. Ataga KI. Hypercoagulability and thrombotic complications in haemolytic anemias. Haematol. 2009;94:1481-4.
9. Cappellini MD, Poggiali E, Taher AT, Musallam KM. Hypercoagulability in β-thalassemia: a status quo. Expert Rev Hematol. 2012;5:505-11.
10. Yashar VBB, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A. Phosphatidylserine in the outer leaflet of red blood cells from β-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol. 1993;44:63-5.
11. Panigrahi I, Agarwal S. Thromboembolic complications in betathalassemia: beyond the horizon. Thromb Res. 2007;120:783-9. (Pubitemid 47422335)
12. Setty BN, Kulkani S, Rao AK, Stuart MJ. Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation. Blood. 2000;96:1119-24. (Pubitemid 30616882)
13. Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood. 2003;102: 2678-83. (Pubitemid 37193612)
14. Habib A, Kunzelmann C, Shamseddeen W, Zobairi F, Freyssinet JM, Taher A. Elevated levels of circulating procoagulant microparticles in patients with β-thalassemia intermedia. Haematologica. 2008;93:941-2. (Pubitemid 351821736)
15. Baglin T. Using the laboratory to predict recurrent venous thrombosis. Int J Lab Hematol. 2011;33:333-42.
16. van Geffen M, van Heerde WL. Global haemostasis assays, from bench to bedside. Thromb Res. 2012;129:681-7.
17. Soshitova NP, Karamzin SS, Balandina AN, Fadeeva OA, Kretchetova AV, Galstian GM, et al. Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics. Blood Coagul Fibrinolysis. 2012;23:498-507.
18. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoorf R, et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 2002;32:249-53. (Pubitemid 37490547)
19. Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost. 2007;97:425-34. (Pubitemid 46437805)
20. Ovanesov MV, Panteleev MA, Sinauridze EI, Kireev DA, Plyushch OP, Kopylov KG, et al. Mechanisms of action of recombinant activated factor VII in the context of tissue factor concentration and distribution. Blood Coagul Fibrinolysis. 2008;19:743-55.
21. Parunov LA, Fadeeva OA, Balandina AN, Soshitova NP, Kopylov KG, Kumskova MA, et al. Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation. J Thromb Haemost. 2011;9:1825-34.
22. Ovanesov MV, Krasotkina JV, Ul'yanova LI, Abushinova KV, Plyushch OP, Domogatskii SP, et al. Hemophilia A and B are associated with abnormal spatial dynamics of clot growth. Biochim Biophys Acta. 2002;1572:45-57. (Pubitemid 35223055)
23. Ovanesov MV, Lopatina EG, Saenko EL, Ananyeva NM, Ul'yanova LI, Plyushch OP, et al. Effect of factor VIII on tissue factor-initiated spatial clot growth. Thromb Haemost. 2003;89:235-42. (Pubitemid 36227273)
24. Sinauridze EI, Volkova RI, Krasotkina YV, Sarbash VI, Ataullakhanov FI. Dynamics of clot growth induced by thrombin diffusing into nonstirred citrate human plasma. Biochim Biophys Acta. 1998;1425:607-16. (Pubitemid 28546695)
25. Panteleev MA, Ovanesov MV, Kireev DA, Shibeko AM, Sinauridze EI, Ananyeva NM, Butylin AA, Saenko EL, Ataullakhanov FI. Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively. Biophys J. 2006;90:1489-500.
26. Ovanesov MV, Ananyeva NM, Panteleev MA, Ataullakhanov FI, Saenko EL. Initiation and propagation of coagulation from tissue factor-bearing cell monolayers to plasma: initiator cells do not regulate spatial growth rate. J Thromb Haemost. 2005;3:321-31. (Pubitemid 41623621)